Alamar Biosciences, Inc. has launched the first commercial eMTBR-Tau immunoassay, now available in the NULISAseq Neuro 220 multiplexed panel kits, immediately deployable on the entire installed base of ARGO HT instruments, and as a single-plex assay through the company’s Technology Access Program.
